Barclays PLC Connect Biopharma Holdings LTD Call Options Transaction History
Barclays PLC
- $377 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CNTB
# of Institutions
12Shares Held
3.05MCall Options Held
0Put Options Held
0-
Bml Capital Management, LLC Zionsville, IN2.09MShares$2.39 Million1.77% of portfolio
-
Ubs Oconnor LLC Chicago, IL511KShares$582,1990.05% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny176KShares$200,0690.0% of portfolio
-
Black Rock Inc. New York, NY104KShares$118,4350.0% of portfolio
-
Callan Capital, LLC La Jolla, CA41.8KShares$47,6780.0% of portfolio
About Connect Biopharma Holdings Ltd
- Ticker CNTB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,015,800
- Market Cap $62.7M
- Description
- Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for t...